Marijuana Use Among Women of Reproductive Age With Disabilities


      Despite the increasing prevalence and potential adverse health outcomes associated with marijuana use, limited research exists related to its use in women of reproductive age with disabilities. The purpose of this study is to examine the past-month marijuana use in women of reproductive age with disabilities.


      Data from the 2015–2019 National Survey on Drug Use and Health included 76,765 women of reproductive age (18–44 years). Descriptive statistics and adjusted logistic regression analyses were conducted to assess the associations between past-month marijuana use and overall disability, including the type of disability.


      In this sample, 12.6% of women reported past-month marijuana use. Approximately, 21% of women with disabilities reported past-month marijuana use, compared with only 11.1% of women without a disability. Marijuana use was more prevalent in women with disabilities who were younger (aged ≤25 years), who were non-Hispanic White, who were nonmarried, who had at least some college education, and who used alcohol or tobacco. Women with disabilities had 1.68 (95% CI=1.57, 1.80) higher odds of reporting past-month marijuana use than those with no disabilities. The odds of past-month marijuana use were higher among those with cognitive (AOR=1.78, 95% CI=1.64, 1.94), sensory (AOR=1.30, 95% CI=1.12, 1.51), and daily activities–related (AOR=1.64, 95% CI=1.49, 1.80) disabilities than among their counterparts without disabilities.


      This study found an increased prevalence of past-month marijuana use among women of reproductive age with disabilities. Enhanced screening and counseling using evidence-based practices during routine care for women with disabilities may be necessary to mitigate marijuana use.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • McCance-Katz EF.
        2019 National Survey of Drug Use and Health (NSDUH) releases.
        Substance Abuse and Mental Health Services Administration, Rockville, MDPublished 2020
        • Coleman-Cowger VH
        • Koszowski B
        • Rosenberry ZR
        • Terplan M.
        Factors associated with early pregnancy smoking status among low-income smokers.
        Matern Child Health J. 2016; 20: 1054-1060
        • Jarlenski M
        • Koma JW
        • Zank J
        • Bodnar LM
        • Bogen DL
        • Chang JC.
        Trends in perception of risk of regular marijuana use among U.S. pregnant and nonpregnant reproductive-aged women.
        Am J Obstet Gynecol. 2017; 217: 705-707
        • Ewing AC
        • Schauer GL
        • Grant-Lenzy AM
        • Njai R
        • Coy KC
        • Ko JY.
        Current marijuana use among women of reproductive age.
        Drug Alcohol Depend. 2020; 214108161
        • National Academies of Sciences, Engineering, and Medicine
        The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.
        The National Academies Press, Washington, DC2017
        • Brents LK.
        Marijuana, the endocannabinoid system and the female reproductive system.
        Yale J Biol Med. 2016; 89 ( Accessed March 8, 2021): 175-191
        • Horner-Johnson W
        • Dissanayake M
        • Wu JP
        • Caughey AB
        • Darney BG.
        Pregnancy intendedness by maternal disability status and type in the United States.
        Perspect Sex Reprod Health. 2020; 52: 31-38
        • Alshaarawy O
        • Anthony JC.
        Cannabis use among women of reproductive age in the United States: 2002-2017.
        Addict Behav. 2019; 99106082
        • Crume TL
        • Juhl AL
        • Brooks-Russell A
        • Hall KE
        • Wymore E
        • Borgelt LM.
        Cannabis use during the perinatal period in a state with legalized recreational and medical marijuana: the association between maternal characteristics, breastfeeding patterns, and neonatal outcomes.
        J Pediatr. 2018; 197: 90-96
        • Bailey BA
        • Wood DL
        • Shah D.
        Impact of pregnancy marijuana use on birth outcomes: results from two matched population-based cohorts.
        J Perinatol. 2020; 40: 1477-1482
        • Grzeskowiak LE
        • Grieger JA
        • Andraweera P
        • et al.
        The deleterious effects of cannabis during pregnancy on neonatal outcomes.
        Med J Aust. 2020; 212: 519-524
        • Kharbanda EO
        • Vazquez-Benitez G
        • Kunin-Batson A
        • Nordin JD
        • Olsen A
        • Romitti PA.
        Birth and early developmental screening outcomes associated with cannabis exposure during pregnancy.
        J Perinatol. 2020; 40: 473-480
        • Gunn JKL
        • Rosales CB
        • Center KE
        • et al.
        Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis.
        BMJ Open. 2016; 6e009986
        • Warshak CR
        • Regan J
        • Moore B
        • Magner K
        • Kritzer S
        • Van Hook J.
        Association between marijuana use and adverse obstetrical and neonatal outcomes.
        J Perinatol. 2015; 35: 991-995
        • Hayatbakhsh MR
        • Flenady VJ
        • Gibbons KS
        • et al.
        Birth outcomes associated with cannabis use before and during pregnancy.
        Pediatr Res. 2012; 71: 215-219
        • Corsi DJ
        • Donelle J
        • Sucha E
        • et al.
        Maternal cannabis use in pregnancy and child neurodevelopmental outcomes.
        Nat Med. 2020; 26: 1536-1540
        • Guille C
        • Aujla R.
        Developmental consequences of prenatal substance use in children and adolescents.
        J Child Adolesc Psychopharmacol. 2019; 29: 479-486
        • Ko JY
        • Tong VT
        • Bombard JM
        • Hayes DK
        • Davy J
        • Perham-Hester KA.
        Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: a population-based study.
        Drug Alcohol Depend. 2018; 187: 72-78
        • Conner SN
        • Bedell V
        • Lipsey K
        • Macones GA
        • Cahill AG
        • Tuuli MG.
        Maternal marijuana use and adverse neonatal outcomes: a systematic review and meta-analysis.
        Obstet Gynecol. 2016; 128: 713-723
        • van Gelder MM
        • Reefhuis J
        • Caton AR
        • et al.
        Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study.
        Drug Alcohol Depend. 2010; 109: 243-247
        • Paul SE
        • Hatoum AS
        • Fine JD
        • et al.
        Associations between prenatal cannabis exposure and childhood outcomes: results from the ABCD Study.
        JAMA Psychiatry. 2021; 78: 64-76
        • Glazier RE
        • Kling RN.
        Recent trends in substance abuse among persons with disabilities compared to that of persons without disabilities.
        Disabil Health J. 2013; 6: 107-115
        • Hasin DS
        • Shmulewitz D
        • Sarvet AL.
        Time trends in U.S. cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings.
        Am J Drug Alcohol Abuse. 2019; 45: 623-643
        • Stetten N
        • Pomeranz J
        • Moorhouse M
        • Yurasek A
        • Blue AV.
        The level of evidence of medical marijuana use for treating disabilities: a scoping review.
        Disabil Rehabil. 2020; 42: 1190-1201
        • Okoro CA
        • Hollis ND
        • Cyrus AC
        • Griffin-Blake S.
        Prevalence of disabilities and health care access by disability status and type among adults - United States, 2016.
        MMWR Morb Mortal Wkly Rep. 2018; 67: 882-887
        • Kitsantas P
        • Krall JR
        • Ramos Y
        • Pollack AZ
        • Kornides M.
        Marijuana use among pregnant women with mental health-related disabilities.
        Womens Reprod Health. 2020; 7: 49-59
        • Center for Behavioral Health Statistics and Quality
        2018 National Survey on Drug Use and Health public use file codebook.
        Substance Abuse and Mental Health Services Administration, Rockville, MD2019 ( October 22Accessed XXX)
        • Altman B
        • Bernstein A.
        Disability and health in the United States, 2001-2005.
        National Center for Health Statistics, Hyattville, MDPublished 2008
        • Bloom TL
        • Mosher W
        • Alhusen J
        • Lantos H
        • Hughes RB.
        Fertility desires and intentions among U.S. women by disability status: findings from the 2011-2013 National Survey of Family Growth.
        Matern Child Health J. 2017; 21: 1606-1615
        • Iezzoni LI.
        Eliminating health and health care disparities among the growing population of people with disabilities.
        Health Aff (Millwood). 2011; 30: 1947-1954
        • American College of Obstetricians and Gynecologists Committee on Obstetric Practice
        Committee opinion no. 637: marijuana use during pregnancy and lactation.
        Obstet Gynecol. 2015; 126: 234-238
      1. U.S. Surgeon General's advisory: marijuana use and the developing brain. Office of the Surgeon General. Updated August 29, 2019. Accessed May 4, 2021.

        • Center for Behavioral Health Statistics and Quality
        National Survey on Drug Use and Health (NSDUH): summary of methodological studies, 1971-2014.
        Substance Abuse and Mental Health Services Administration, Rockville, MDPublished November 2014 (Accessed XXX)